Trial Profile

Clinical study on the safety and efficacy of conversion from selegiline to rasagiline in patients with Parkinson's disease and sleep disorders. Prospective, open, explorative study on conversion of selegiline to rasagiline. [Klinische Untersuchung zur Verträglichkeit und Wirksamkeit nach Umstellung von Selegilin auf Rasagilin bei Patienten mit Morbus Parkinson und Schlafstörungen. Prospektive, offene, explorative Studie mit Umstellung von Selegilin auf Rasagilin.]

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 07 Jan 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Jan 2014 Planned initiation date changed to 7 Jul 2008 as reported in European Clinical Trials Database.
18 Jul 2011 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com